FIELD: medicine. SUBSTANCE: proposed eye drops has, wt.-%: sodium succinate hexahydrate 0.3; sodium citrate 5.5-hydrate 0.3; sorbit 1.0; sodium chloride 0.54; L-glutamic acid 0.2; riboflavin mononucleotidephosphate 0.01; benzalkonium chloride 0.01, and distilled water for injection - the rest. EFFECT: improved energy metabolism in cornea posterior epithelium cells at disturbed metabolism.
| Title | Year | Author | Number |
|---|---|---|---|
| EYE DROPS | 1997 |
|
RU2121825C1 |
| OCULAR DROPS "NEOKERATONIK" | 1997 |
|
RU2127099C1 |
| OCULAR DROPS "PYROTONIK" | 1997 |
|
RU2127100C1 |
| MEDIUM FOR EYE CORNEA CONSERVATION | 1993 |
|
RU2069951C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING CORNEAL EDEMAS | 2001 |
|
RU2197923C1 |
| PHARMACEUTICAL ANTIGLAUCOMA COMPOSITION | 2009 |
|
RU2402316C2 |
| METHOD FOR TREATING DYSTROPHIC CORNEAL DISEASES AND CORNEA TRANSPLANTATION DISEASES | 2000 |
|
RU2185176C2 |
| METHOD FOR ESTIMATION OF VIABILITY OF DONOR CORNEA | 1993 |
|
RU2070009C1 |
| METHOD OF INDICATION ESTIMATION FOR THROUGH KERATOPLASTY | 1990 |
|
RU2007150C1 |
| METHOD FOR PREDICTING OCCURRENCE OF CORNEAL COMPLICATIONS AFTER PERFORMING SURGICAL INTERVENTION ON EYEBALL IN DIABETES MELLITUS PATIENTS | 1998 |
|
RU2177711C2 |
